Quest Diagnostics Inc (DGX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 03-2024 | 12-2023 | 09-2023 | 06-2023 | 03-2023 | |
| Sales | 2,366,000 | 2,288,000 | 2,295,000 | 2,338,000 | 2,331,000 |
| Cost of Goods | 1,595,000 | 1,552,000 | 1,541,000 | 1,546,000 | 1,560,000 |
| Gross Profit | 771,000 | 736,000 | 754,000 | 792,000 | 771,000 |
| Operating Expenses | 471,000 | 469,000 | 412,000 | 444,000 | 466,000 |
| Operating Income | 300,000 | 267,000 | 342,000 | 348,000 | 305,000 |
| Interest Expense | 43,000 | 40,000 | 40,000 | 37,000 | 35,000 |
| Other Income | 17,000 | 18,000 | 3,000 | 13,000 | 12,000 |
| Pre-tax Income | 274,000 | 245,000 | 305,000 | 324,000 | 282,000 |
| Income Tax | 66,000 | 40,000 | 68,000 | 75,000 | 65,000 |
| Net Income Continuous | 208,000 | 205,000 | 237,000 | 249,000 | 217,000 |
| Minority Interests | 14,000 | 13,000 | 12,000 | 14,000 | 15,000 |
| Net Income | $194,000 | $192,000 | $225,000 | $235,000 | $202,000 |
| EPS Basic Total Ops | 1.74 | 1.72 | 1.99 | 2.08 | 1.80 |
| EPS Basic Continuous Ops | 1.87 | 1.83 | 2.12 | 2.22 | 1.94 |
| EPS Diluted Total Ops | 1.72 | 1.70 | 1.96 | 2.05 | 1.78 |
| EPS Diluted Continuous Ops | 1.86 | 1.85 | 2.08 | 2.18 | 1.92 |
| EPS Diluted Before Non-Recurring Items | N/A | 2.15 | 2.22 | 2.30 | 2.04 |
| EBITDA(a) | $416,000 | $376,000 | $453,000 | $460,000 | $412,000 |